|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Hyperparathyroidism | |||||
| Hypocalcemia | |||||
| Hypoparathyroidism | |||||
| Parathyroid Neoplasm | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Parathyroid Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Calcium Metabolism Disorders | |||||
| Endocrine Gland Neoplasms | |||||
| Endocrine System Diseases | |||||
| Head and Neck Neoplasms | |||||
| Metabolic Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Parathyroid Diseases | |||||
| Water-Electrolyte Imbalance | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||